DSM-Firmenich AG
AEX:DSFIR

Watchlist Manager

DSM-Firmenich AG

AEX:DSFIR

Watchlist

Dividends

Discount Rate

Price: 102.5 EUR 0.44% Market Closed

Market Cap: 27.2B EUR

Have any thoughts about
DSM-Firmenich AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 102.5 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

DSFIR Alert

DSM-Firmenich AG

102.5

+0.45 (+0.44%)

52 Week Range	85.51 123.65
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

DSM-Firmenich AG

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of DSM-Firmenich AG.

What unique competitive advantages
does DSM-Firmenich AG hold over its rivals?

What risks and challenges
does DSM-Firmenich AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DSM-Firmenich AG.

Provide P/S
for DSM-Firmenich AG.

Provide P/E
for DSM-Firmenich AG.

Provide P/OCF
for DSM-Firmenich AG.

Provide P/FCFE
for DSM-Firmenich AG.

Provide P/B
for DSM-Firmenich AG.

Provide EV/S
for DSM-Firmenich AG.

Provide EV/GP
for DSM-Firmenich AG.

Provide EV/EBITDA
for DSM-Firmenich AG.

Provide EV/EBIT
for DSM-Firmenich AG.

Provide EV/OCF
for DSM-Firmenich AG.

Provide EV/FCFF
for DSM-Firmenich AG.

Provide EV/IC
for DSM-Firmenich AG.

Show me price targets
for DSM-Firmenich AG made by professional analysts.

What are the Revenue projections
for DSM-Firmenich AG?

How accurate were the past Revenue estimates
for DSM-Firmenich AG?

What are the Net Income projections
for DSM-Firmenich AG?

How accurate were the past Net Income estimates
for DSM-Firmenich AG?

What are the EPS projections
for DSM-Firmenich AG?

How accurate were the past EPS estimates
for DSM-Firmenich AG?

What are the EBIT projections
for DSM-Firmenich AG?

How accurate were the past EBIT estimates
for DSM-Firmenich AG?

Compare the revenue forecasts
for DSM-Firmenich AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DSM-Firmenich AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DSM-Firmenich AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of DSM-Firmenich AG compared to its peers.

Compare the P/E ratios
of DSM-Firmenich AG against its peers.

Discuss the investment returns and shareholder value creation
comparing DSM-Firmenich AG with its peers.

Analyze the financial leverage
of DSM-Firmenich AG compared to its main competitors.

Show all profitability ratios
for DSM-Firmenich AG.

Provide ROE
for DSM-Firmenich AG.

Provide ROA
for DSM-Firmenich AG.

Provide ROIC
for DSM-Firmenich AG.

Provide ROCE
for DSM-Firmenich AG.

Provide Gross Margin
for DSM-Firmenich AG.

Provide Operating Margin
for DSM-Firmenich AG.

Provide Net Margin
for DSM-Firmenich AG.

Provide FCF Margin
for DSM-Firmenich AG.

Show all solvency ratios
for DSM-Firmenich AG.

Provide D/E Ratio
for DSM-Firmenich AG.

Provide D/A Ratio
for DSM-Firmenich AG.

Provide Interest Coverage Ratio
for DSM-Firmenich AG.

Provide Altman Z-Score Ratio
for DSM-Firmenich AG.

Provide Quick Ratio
for DSM-Firmenich AG.

Provide Current Ratio
for DSM-Firmenich AG.

Provide Cash Ratio
for DSM-Firmenich AG.

What is the historical Revenue growth
over the last 5 years for DSM-Firmenich AG?

What is the historical Net Income growth
over the last 5 years for DSM-Firmenich AG?

What is the current Free Cash Flow
of DSM-Firmenich AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for DSM-Firmenich AG.

P/OCF
Price to OCF

21.6

Current

22.2

Median

13.6

Industry

Lower than median

Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF

21.6

Market Cap

27.3B EUR

Operating Cash Flow

1.3B EUR

All Countries

Forward Multiples

			Market Cap	P/OCF
CH	D	DSM-Firmenich AG AEX:DSFIR	27.3B EUR	21.6
US		Sherwin-Williams Co NYSE:SHW	97.8B USD	31.2
JP		Shin-Etsu Chemical Co Ltd TSE:4063	11.2T JPY	13.5
US		Ecolab Inc NYSE:ECL	70.6B USD	24.3
CH		Givaudan SA SIX:GIVN	35.4B CHF	24.2
US		Dupont De Nemours Inc NYSE:DD	34.8B USD	18.9
CN		Wanhua Chemical Group Co Ltd SSE:600309	245.1B CNY	9.5
US		PPG Industries Inc NYSE:PPG	28.6B USD	14.5
IN		Asian Paints Ltd NSE:ASIANPAINT	2.4T INR	39
DK		Novozymes A/S CSE:NZYM B	165.6B DKK	39.9
US		International Flavors & Fragrances Inc NYSE:IFF	22.9B USD	17


CH	D	DSM-Firmenich AG AEX:DSFIR	Average P/OCF: 23.1 21.6
US		Sherwin-Williams Co NYSE:SHW	31.2
JP		Shin-Etsu Chemical Co Ltd TSE:4063	13.5
US		Ecolab Inc NYSE:ECL	24.3
CH		Givaudan SA SIX:GIVN	24.2
US		Dupont De Nemours Inc NYSE:DD	18.9
CN		Wanhua Chemical Group Co Ltd SSE:600309	9.5
US		PPG Industries Inc NYSE:PPG	14.5
IN		Asian Paints Ltd NSE:ASIANPAINT	39
DK		Novozymes A/S CSE:NZYM B	39.9
US		International Flavors & Fragrances Inc NYSE:IFF	17

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/OCF

N/A

2-Years Forward

P/OCF

N/A

3-Years Forward

P/OCF

N/A

DSM-Firmenich AG
AEX:DSFIR

P/OCF
Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG AEX:DSFIR

P/OCF Price to OCF

P/OCF Forward Multiples

See Also

Company

Help

Tools

Stocks

DSM-Firmenich AG
AEX:DSFIR

P/OCF
Price to OCF